Page 3 - Temporary Program Director News Today : Breaking News, Live Updates & Top Stories | Vimarsana

March 10, 2021 11:00 AM  to  March 10, 2021 5:30 PM Alexandria (virtual)

March 9th, 2021 2pm-4pm ET March 9, 2021 2:00 PM  to  March 9, 2021 4:00 PM Virtual Meeting NSF, through the Office of Advanced Cyberinfrastructure (OAC), has published a vision that calls for the broad availability and innovative use of an agile, integrated, robust, trustworthy and sustainable CI ecosystem that can drive new thinking and transformative discoveries in all areas of S&E research and education. In support of this vision, NSF has released two solicitations as part of the Advanced Cyberinfrastructure Coordination Ecosyst...

March 8, 2021 1:00 PM  to  March 8, 2021 2:00 PM Virtual Join us Monday, March 8th from 1-2PM EST for DEB’s next Virtual Office Hour. Program Officers will provide information for Early Career Researchers.  Representatives from each DEB cluster will be available for questions. To participate, please use the registration link below. Upcoming DEB Virtual Office Hours are announced ahead of time on DEBrief, so we suggest you also sign up for blog notifications. If you can’t make it to this or any future office hours, don’t wo...

March 2, 2021 11:00 AM  to  March 2, 2021 12:00 PM https://nsf.zoomgov.com/webinar/register/WN_FJQ4aLRGSKuTd2gOQgiH7A As noted in a recent announcement and in order to answer any questions the community may have about BIO's efforts in response to the COVID-19 pandemic or the support available to the wider community, we hosted a BIO-wide virtual office hour on Tuesday, March 2 from 11AM to 12PM Eastern. A recording of the event (with an integrated transcript) is available at the link below:

March 4th, 2021 2:00pm-3:30pm March 4, 2021 2:00 PM  to  March 4, 2021 3:30 PM Virtual Meeting Talk Abstract: I will discuss our lab’s efforts, together with collaborators, to understand the SARS-CoV-2 virus in atomic detail, with the goals to better understand molecular recognition of the virus and host cell receptors, antibody binding and design, and the search for novel therapeutics.  I will focus on our studies of the spike protein, its glycan shield, its interactions with the human ACE2 receptor, our efforts to model the SAR...